1. Metabolic Reprogramming in Thyroid Carcinoma
   Raquel Guimaraes Coelho et al, 2018, Frontiers in Oncology CrossRef
2. miR-181a, delivered by hypoxic PTC-secreted exosomes, inhibits DACT2 by downregulating MLL3, leading to YAP-VEGF-mediated angiogenesis
   Yingxue Wang et al, 2021, Molecular Therapy - Nucleic Acids CrossRef
3. Identification of soluble tissue‑derived biomarkers from human thyroid tissue explants maintained on a microfluidic device
   Andrew Riley et al, 2021, Oncology Letters CrossRef
4. Association of pigment epithelium derived factor expression with cancer progression and prognosis: a meta-analysis study
   Guo Cheng et al, 2021, Discover Oncology CrossRef
5. Upregulated pigment epithelium-derived factor (PEDF) promotes trophoblast apoptosis and inhibits invasion in preeclampsia
   Ying Wu et al, 2021, Reproductive Biology CrossRef
6. Advances in metabolomics of thyroid cancer diagnosis and metabolic regulation
   Raziyeh Abooshahab et al, 2019, Endocrine CrossRef
7. Pigment epithelium-derived factor inhibits lung cancer migration and invasion by upregulating exosomal thrombospondin 1
   Wen-Tsung Huang et al, 2019, Cancer Letters CrossRef
8. The increasing role of pigment epithelium-derived factor in metastasis: from biological importance to a promising target
   Raziyeh Abooshahab et al, 2021, Biochemical Pharmacology CrossRef